Table 1.
Characteristics | Patients N°(%) |
---|---|
Gender | |
Male | 7 (46.7) |
Female | 8 (53.3) |
Age | |
Mean | 52.7 |
HCV genotype | |
1b | 12 (80) |
Other | 3 (20) |
Virogical Response to PEG-INF-α/RBV | |
SVR | 5 (33.3) |
Relapser | 4 (26.7) |
Non Responder | 6 (40) |
APRI SCORE | |
≤0.5 | 8 (53.3) |
0.51-1.5 | 2 (13.4) |
>1.5 | 5 (33.3) |
Log10 HCV-RNA (UI/ml) | |
Mean | 6.16 |
Frequencies IL-27 genotypes | |
A/A | 5 (33.3) |
A/G | 9(60) |
G/G | 1 (6.7) |
A Allele | 14 (93.3) |
Total | 15 |
PegIFN-α, peginterferon-α; RBV, Ribavirin; SVR, Sustained Viral Response; APRI SCORE, AST to Platelet Ratio Index;